Characteristics | Total patients (n = 90) | |
---|---|---|
n | (%) | |
Age | ||
Median | 50 | |
Range | (24–77) | |
ECOG performance | ||
0 | 55 | 61.1 |
1 | 33 | 36.7 |
2 | 2 | 2.2 |
Pathologic findings | ||
Squamous cell carcinoma (SCC) | 84 | 93.3 |
Large cell keratinizing | 18 | 20 |
Large cell non-keratinizing | 47 | 52.2 |
Large cell, not specified | 3 | 3.3 |
SCC, not specified | 14 | 15.6 |
Small cell | 2 | 2.2 |
Others (adenocarcinoma, adenosquamous carcinoma) | 6 | 6.7 |
Tumor shape | ||
Exophytic | 38 | 42.2 |
Infiltrative | 52 | 57.8 |
Parametrial involvement | ||
No | 10 | 11.1 |
Yes | 80 | 88.9 |
Unilateral | 42 | 46.7 |
Bilateral | 38 | 42.2 |
Endocervical extension | ||
No | 6 | 6.7 |
Yes | 37 | 41.1 |
Not confirmed | 47 | 52.2 |
Primary tumor size (cm) | ||
Median | 5 | |
Range | (2–10) | |
Pelvic LN involvement | 73 | 81.1 |
Paraaortic LN involvement | 90 | 100 |
Hydronephrosis | 18 | 20 |
FIGO stage | ||
IB | 10 | 11.1 |
IIB | 39 | 43.3 |
IIIA | 2 | 2.2 |
IIIB | 33 | 36.7 |
IVA | 6 | 6.7 |
Treatment period | ||
Before 2000 | 52 | 57.8 |
2000-present | 38 | 42.2 |